Bellecapital’s Exponent EXPO Stock Holding History

Bellecapital’s Portfolio EXPO Stock Details EXPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,007	Closed	-$217K	–	185
2020 Q3	$217K	Hold	3,007	–	–	0.1%	152
2020 Q2	$243K	Hold	3,007	–	–	0.11%	134
2020 Q1	$216K	Buy	+3,007	New	+$218K	0.14%	127

Other funds holding EXPO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellecapital's EXPO Position: Q4 2020 in Review

Bellecapital sold out of Exponent (EXPO) in Q4 2020, closing a stake of 3,007 shares — an estimated $217K sold.

Bellecapital first reported a position in EXPO in Q1 2020 and held it in 3 quarters. The position peaked at $243K in Q2 2020. 305 funds tracked by Wall St. Rank hold EXPO as of Q4 2020.

Bellecapital reported no remaining Exponent position as of Q4 2020 after selling out during the quarter.
Bellecapital sold 3,007 Exponent shares in Q4 2020, an estimated $217K.
Bellecapital first reported a position in Exponent in Q1 2020 and held it in 3 quarters.
Bellecapital's Exponent position peaked at $243K in Q2 2020.
305 funds tracked by Wall St. Rank held Exponent as of Q4 2020.

Based on Bellecapital's 13F filing for Q4 2020, filed 14 Jan 2021.